{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:36:54Z","timestamp":1792813014957,"version":"4.5.0"},"reference-count":46,"publisher":"Massachusetts Medical Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NEJM Evidence"],"published-print":{"date-parts":[[2022,4,26]]},"DOI":"10.1056\/evidoa2100066","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T09:30:27Z","timestamp":1650965427000},"source":"Crossref","is-referenced-by-count":236,"title":["Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis"],"prefix":"10.1056","volume":"1","author":[{"given":"Tuan","family":"Vu","sequence":"first","affiliation":[{"name":"University of South Florida Morsani College of Medicine, Tampa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[{"name":"Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[{"name":"H\u00f4pital Raymond Poincar\u00e9, University of Versailles, Garches, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[{"name":"Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Aguzzi","sequence":"additional","affiliation":[{"name":"Alexion, AstraZeneca Rare Disease, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Enayetallah","sequence":"additional","affiliation":[{"name":"Alexion, AstraZeneca Rare Disease, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen N.","family":"Beasley","sequence":"additional","affiliation":[{"name":"Alexion, AstraZeneca Rare Disease, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishi","family":"Rampal","sequence":"additional","affiliation":[{"name":"Alexion, AstraZeneca Rare Disease, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James F.","family":"Howard","sequence":"additional","affiliation":[{"name":"The University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13522"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8045-z"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1573-2"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13836"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26695"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0757-2"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013278"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-129"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S261414"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2014.11.022"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8206.1"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00981"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00538"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102712"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419832242"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00917"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30369-1"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195909"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876136"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.01.035"},{"key":"e_1_3_5_24_2","unstructured":"Myasthenia Gravis Foundation of America. MGFA Clinical Classification. 2021 (https:\/\/myasthenia.org\/Portals\/0\/MGFA%20Classification.pdf)."},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.7.1487"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb11015.x"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25198"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9958-8"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06817.x"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23988"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21609"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.5125"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00159-9"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000312374.95186.cc"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1212\/WNL.0000000000011108","article-title":"Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis: a phase 2 randomized control trial","volume":"96","year":"2021","unstructured":"Bril V, Benatar M, Andersen H, et\u00a0al. Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis: a phase 2 randomized control trial. Neurology 2021;96:e853-e865.","journal-title":"Neurology"},{"key":"e_1_3_5_36_2","volume-title":"Placebo effects","unstructured":"Benedetti F. Placebo effects. 2nd ed. Oxford: Oxford University Press, 2014.","edition":"2"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178676"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.024"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0398-y"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16711"},{"key":"e_1_3_5_41_2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/aian.AIAN_551_20","article-title":"The impact of the coronavirus disease-2019 pandemic on the psychological status and quality of life of myasthenia gravis patients","volume":"23","year":"2020","unstructured":"Stojanov A, Stojanov J, Milosevic V, et\u00a0al. The impact of the coronavirus disease-2019 pandemic on the psychological status and quality of life of myasthenia gravis patients. Ann Indian Acad Neurol 2020;23:510-514.","journal-title":"Ann Indian Acad Neurol"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106488"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900866"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061648"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208981"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25529"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23330"}],"container-title":["NEJM Evidence"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T11:55:23Z","timestamp":1700481323000},"score":1,"resource":{"primary":{"URL":"https:\/\/evidence.nejm.org\/doi\/10.1056\/EVIDoa2100066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4,26]]}},"alternative-id":["10.1056\/EVIDoa2100066"],"URL":"https:\/\/doi.org\/10.1056\/evidoa2100066","relation":{},"ISSN":["2766-5526"],"issn-type":[{"value":"2766-5526","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,26]]}}}